Skip to main content
. 2021 May 13;12:661316. doi: 10.3389/fendo.2021.661316

Figure 3.

Figure 3

Genetic Testing and Validation Results. The WES result indicated that the MDM4 amplified in this thymoma cells, which is the unique driver gene in 99 mutated genes among 20,000 exons (A); Immunohistochemical staining showed positivity for MDM4 (B) and negativity for p53 (C); The drug sensitivity test showed that the growth rate of thymoma cells was 41.22% in Nutlin-3a group, compared with 78.66% in the control group, which meant that the thymoma cells were highly sensitive to Nutlin-3a (D).